glp-1 constipation Fiber Intake: Preventing & Side Effects why do glp 1 cause
Description
[DOI] [PubMed] [Google Scholar] 84.Parhizkar H., et al
Two other clinical trials investigating subcutaneous liraglutide, 3.0 mg daily (ClinicalTrials.gov identifier NCT03712098), and subcutaneous dulaglutide, 1.5 mg once weekly (ClinicalTrials.gov identifier NCT03204396), are still recruiting
doi: 10.1210/endo.143.6.8840
No matter the reason someone is using these medications, people might experience some gastrointestinal (GI) discomfort, including: Constipation Diarrhea Nausea Vomiting These side effects are most common when people first start treatment or after a recent dosage adjustment
